



A Case for Change  
National Facts: 
 Coronary heart disease and cerebrovascular disease are leading causes of death in the United States.  
 In 2002, the U. S. Preventive Services Task Force (USPSTF) strongly recommended that clinicians discuss 
aspirin with adults who are at increased risk for coronary heart disease.  
 Evidence from one good quality randomized, controlled trial (RCT), one good quality meta-analysis, and 
two fair quality sub-analyses of RCTs demonstrate that aspirin use in patients without known 
cardiovascular disease (CVD) reduces the number of CVD events. Men in these studies experienced a 
reduction in the number of myocardial infarctions and women experienced a reduction in the number of 
ischemic strokes. Aspirin does not appear to affect CVD mortality or all-cause mortality in either women or 
men. The use of aspirin for primary prevention increases the risk for major bleeding events, primarily 
gastrointestinal bleeding (GIB), in both men and women. Men have an increased risk for hemorrhagic 
strokes with aspirin use. A new RCT and meta-analysis suggest that the risk for hemorrhagic strokes in 




 26.7% of Iowans take aspirin daily (most were over age 45); 
 8% of Iowans have a medical condition where aspirin therapy is not recommended.ii 
 
This toolkit will:  
 Provide Iowa health care providers with educational resources to better inform themselves and their 
patients about preventing heart attack and stroke through daily aspirin therapy. 









Clinical Guidelines and Protocols 
Aspirin for the Prevention of Cardiovascular Disease. U.S. Preventative Services 
Task Force. March 2009.  
 
U.S. Preventative Services Task Force guidelines related to aspirin use and the 
prevention of cardiovascular disease.  Very thorough web page includes links to the 
recommendation statement, supporting article, evidence synthesis, clinical summary 
patient brochures, and clinician fact sheets.  Available for download at no cost. 
Aspirin for the Prevention of Cardiovascular Disease, March 2009 
Recommendation Statement (PDF File, 335 KB; PDF Help) 
Supporting Article (PDF File, 160 KB; PDF Help)  
Evidence Synthesis (PDF File, 145 KB; PDF Help)  





Clinical Summary of U.S. Preventive Services Task Force 
Recommendation-Aspirin For the Prevention of Cardiovascular 
Disease, Agency for Healthcare Research and Quality (AHRQ) 




Aspirin for the Primary Prevention of Cardiovascular Events: An Update of 
the Evidence for the U.S. Preventive Services Task Force. Tracy Wolff, MD, 
MPH; Therese Miller, Dr PH; and Stephen Ko, MD, MPH.  Published in the Annals 
of Internal Medicine.  March 2009.  
 
Clinical guidelines regarding the use of aspirin to reduce the risk for myocardial 







Primary Prevention in the Adult, American Heart Association. 
 
AHA Recommendation  
The decline in death rates from cardiovascular disease in the United States is 
probably due largely to people adopting a healthier lifestyle. That's why it's 
important for healthcare professionals to implement American Heart Association 
guidelines for primary and secondary prevention. 
Aspirin Use in Adults 
Goal: Low-dose aspirin in people at higher risk of coronary heart disease (especially 
those with a 10-year CHD risk of 10 percent or greater). 
Recommendations 
 Do not recommend for patients with aspirin intolerance (or allergy).  
 Low-dose aspirin increases risk for gastrointestinal bleeding and 
hemorrhagic stroke. Do not use in people at increased risk for these 
diseases.  
 Benefits of reducing cardiovascular risk outweigh these risks in most 
patients with higher coronary risk.  
 Doses of 75–160 mg per day are as effective as higher doses. Consider 75–
160 mg aspirin per day for people at higher risk (especially those with a 10-




The Seventh Report of the Joint National Committee on Prevention, Detection, 
Evaluation, and Treatment of High Blood Pressure - Complete Report  
JNC 7 Complete Report: The Science Behind the New Guidelines 
This complete version of the updated guidelines for hypertension is written for the 
health care professional who wants to understand the science behind the new 
recommendations on high blood pressure. The JNC 7 Complete Report focuses on 
the new evidence, including a revised treatment algorithm, drug tables, and more. 
Get this for the health professional or researcher who needs to understand the full 
scope and significance of the new findings on high blood pressure.  




Educational Materials  
Provider Education 
Using Aspirin for the Primary Prevention of Cardiovascular Disease. U.S. 
Preventive Services Task Force. March 2009.  
 
Provides information about using aspirin to prevent first myocardial infarctions 






For Men: Talk With Your Health Care Provider About Taking Aspirin to 
Prevent Heart Attacks. U.S. Department of Veterans Affairs and the U.S. 
Department of Health and Human Services. April 2009.  
 
**A brochure for men which explains why aspirin can effectively prevent heart 
attacks.  Has a small area on the back panel you can place your clinic’s contact 




For Women: Talk With Your Health Care Provider About Taking Aspirin to 
Prevent Strokes. U.S. Department of Veterans Affairs and the U.S. Department of 
Health and Human Services. April 2009.  
 
**A brochure specifically designed for a woman that provides information about 
aspirin’s usefulness in preventing strokes. Has a small area on the back panel you 





Aspirin, Heart Disease, and Stroke. The American Heart Association. 2010.  
 
A booklet about aspirin therapy and its ability to be used for the prevention of heart 
disease and stroke as well as its use as acute event treatment.  







E36A&item=346410   
Aspirin for Reducing Your Risk of Heart Attack and Stroke: KNOW THE 
FACTS; United States Food and Drug Administration, 04/30/2009 
A brochure describing the facts about aspirin use to reduce the risk of heart attack 








Web Sites of Interest 
Aspirin Foundation Web Site 
The Aspirin Foundation is a source of information for consumers, health 
professionals and journalists on all scientific and general aspects of aspirin 
usage. By using this resource you can obtain up-to-date information or 
receive help in constructing media articles. The Foundation also provides 
support for medical and scientific studies, meetings and symposia which 
will extend the knowledge base on aspirin. 
 
http://www.aspirin-foundation.com/uses/cardio.html    
Daily Aspirin Therapy: Understand the Benefits and Risks.  Mayo 
Foundation for Medical Education and Research.  2010.  
 
Website developed to help patients understand the benefits and risks of 




Healthcare Professional Organizations 
 American Heart Association 
 American Stroke Association 
 Centers for Disease Control and Prevention 
 Joint National Committee 




Funding for this project was made available under Cooperative Agreement 5U50DP000734-02 from 
the Centers for Disease Control and Prevention, Division of Heart Disease and Stroke Prevention with 
the Iowa Department of Public Health, Bureau of Chronic Disease Prevention and Management, 
Heart Disease and Stroke Prevention Program in 2011. 
 
For more about this project, contact Terry Meek, the Heart Disease and Stroke Prevention Project 
Coordinator for the Iowa Department of Public Health at tmeek@idph.state.ia.us or 515-281-6016. 
                                                          
i
 Aspirin for the Primary Prevention of Cardiovascular Events: An Update of the Evidence for the U.S. Preventive Services Task Force, AHRQ 
Puclication No. 09-05129-EF-1, March 2009. 
ii
 Centers for Disease Control and Prevention, Behavioral and Risk Factor Surveillance System (BRFSS), State of Iowa data, 2009. 
